BNT162b2 Against COVID-19-Associated Emergency Department and Urgent Care Visits Among Children 5-11 Years of Age: A Test Negative Design

被引：3

作者：

Tartof, Sara Y. ^{[1
,2
]}

Frankland, Timothy B. ^{[3
]}

Puzniak, Laura ^{[4
]}

Slezak, Jeff M. ^{[1
]}

Hong, Vennis ^{[1
]}

Takhar, Harpreet ^{[1
]}

Ogun, Oluwaseye A. ^{[1
]}

Simmons, Sarah ^{[1
]}

Xie, Fagen ^{[1
]}

Zamparo, Joann ^{[4
]}

Ackerson, Bradley K. ^{[5
]}

Jodar, Luis ^{[4
]}

McLaughlin, John M. ^{[4
]}

机构：

[1] Kaiser Permanente Southern Calif, Dept Res & Evaluat, 1000 S Los Robles,2nd Floor, Pasadena, CA 91101 USA

[2] Kaiser Permanente Bernard J Tyson Sch Med, Dept Hlth Syst Sci, Pasadena, CA USA

[3] Kaiser Permanente Hawaii Ctr Integrated Hlth Care, Honolulu, HI USA

[4] Pfizer Inc, Collegeville, PA USA

[5] Southern Calif Permanente Med Grp, Harbor City, CA USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2023年 / 12卷 / 03期

关键词：

BNT162b2; booster; COVID-19; delta; effectiveness; Kaiser Permanente; omicron; pediatric; real-world; SARS-CoV-2; test-negative; United States; VACCINE;

D O I：

10.1093/jpids/piad005

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

In a 1:1 matched test-negative design among 5- to 11-year-olds in the Kaiser Permanente Southern California health system (n = 3984), BNT162b2 effectiveness against the omicron-related emergency department or urgent care encounters was 60% [95%CI: 47-69] <3 months post-dose-two and 28% [8-43] after >= 3 months. A booster improved protection to 77% [53-88].

引用

页码：177 / 179

页数：3

共 35 条

[31] Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021
Ruiz, M. A. Sanchez
Adonias, G.
Robaglia-Schlupp, A.
Rapilly, F.
Chabert, M.
Ramalli, L.
Reilhes, O.
Bruel, C.
Malfait, P.
Chaud, P.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (07) : 2586 - 2591
[32] Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study
Muhsen, Khitam
Maimon, Nimrod
Mizrahi, Ami
Bodenheimer, Omri
Cohen, Dani
Maimon, Michal
Grotto, Itamar
Dagan, Ron
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E755 - E763
[33] Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial
Wittawatmongkol, Orasri
Bunjoungmanee, Pornumpa
Kosalaraksa, Pope
Laoprasopwattana, Kamolwish
Boonsathorn, Sophida
Chantasrisawad, Napaporn
Sudjaritruk, Tavitiya
Niyomnaitham, Suvimol
Senawong, Sansnee
Srisutthisamphan, Kanjana
Toh, Zheng Quan
Rungmaitree, Supattra
Nanthapisal, Sira
Phanthanawiboon, Supranee
Khantee, Puttichart
Techasaensiri, Chonnamet
Hirankarn, Nattiya
Pangprasertkul, Sipang
Chokephaibulkit, Kulkanya
VACCINE, 2023, 41 (40) : 5834 - 5840
[34] Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: a test-negative case-control study using the id.DRIVE platform
Nguyen, Jennifer L.
Mitratza, Marianna
Volkman, Hannah R.
de Munter, Leonie
Tran, Thao Mai Phuong
Marques, Catia
Mustapha, Mustapha
Valluri, Srinivas
Yang, Jingyan
Anton, Andres
Casas, Irma
Conde-Sousa, Eduardo
Drikite, Laura
Gruener, Beate
Icardi, Giancarlo
Kate, Gerrit Luit ten
Martin, Charlotte
Mira-Iglesias, Ainara
Orrico-Sanchez, Alejandro
Otero-Romero, Susana
Rohde, Gernot
Jodar, Luis
Mclaughlin, John M.
Bollaerts, Kaatje
ECLINICALMEDICINE, 2025, 79
[35] Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
Thompson, Mark G.
Natarajan, Karthik
Irving, Stephanie A.
Rowley, Elizabeth A.
Griggs, Eric P.
Gaglani, Manjusha
Klein, Nicola P.
Grannis, Shaun J.
DeSilva, Malini B.
Stenehjem, Edward
Reese, Sarah E.
Dickerson, Monica
Naleway, Allison L.
Han, Jungmi
Konatham, Deepika
McEvoy, Charlene
Rao, Suchitra
Dixon, Brian E.
Dascomb, Kristin
Lewis, Ned
Levy, Matthew E.
Patel, Palak
Liao, I-Chia
Kharbanda, Anupam B.
Barron, Michelle A.
Fadel, William F.
Grisel, Nancy
Goddard, Kristin
Yang, Duck-Hye
Wondimu, Mehiret H.
Murthy, Kempapura
Valvi, Nimish R.
Arndorfer, Julie
Fireman, Bruce
Dunne, Margaret M.
Embi, Peter
Azziz-Baumgartner, Eduardo
Zerbo, Ousseny
Bozio, Catherine H.
Reynolds, Sue
Ferdinands, Jill
Williams, Jeremiah
Link-Gelles, Ruth
Schrag, Stephanie J.
Verani, Jennifer R.
Ball, Sarah
Ong, Toan C.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (04): : 139 - 145

← 1 2 3 4 →